Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Cetuximab 250 / Paclitaxel 30 / Carboplatin 1 / Radiation, Head and Neck Tumors, Cycle 7-11

Protocol-ID: 1244 V1.1 (Mini), CETU250/PACL30/CRBP1/Radiation, Head and Neck Tumors, C7-11

Indication(s)

  • Head and Neck Tumors (Squamous Cell); ICD-10 C76.0
  • Nasopharyngeal Carcinoma; ICD-10 C11.8, C11.9, C11.-
ST
Radiotherapy: simultaneous Radiation in week 9-13
Die Radiotheraoie erfolgt einmal täglich a 200 cGy, bis zu einer Gesamtstrahlendosis von 68–72 Gy
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 25.02.2020